Research supported by drug companies downplayed addiction risks

12/31/2012 | Washington Post, The

Marketing and research supported by drug companies underestimated the risks of addiction with OxyContin and other opiates, according to this article. Findings that withdrawal symptoms associated with opioid use are not widespread have been rejected or questioned over the past few years.

View Full Article in:

Washington Post, The

Published in Brief: